Article citationsMore>>

William, J.M., Jill, L.O., Leonard, V., et al. (2008) Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson’s disease: An open-label, phase I trial. The Lancet Neurology, 7, 400-408. doi:10.1016/S1474-4422(08)70065-6

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top